MicroRNA 4690 (MIR4690)

MicroRNA 4690 (MIR4690) is a non-coding RNA gene that encodes a short (20–24 nucleotide) RNA molecule known as a microRNA. Like other microRNAs, MIR4690 regulates gene expression by binding to specific messenger RNAs (mRNAs) and suppressing their translation or promoting their degradation. The process involves the cleavage of its primary transcript by Drosha to form a precursor miRNA and further processing by Dicer to yield the mature miRNA, which participates in the RNA-induced silencing complex (RISC)[1][3]. While the general functional role of microRNAs is well established—post-transcriptional control of gene expression affecting cellular processes like proliferation, differentiation, and apoptosis—there is very little or no direct experimental data on the unique biological targets, disease relevance, or therapeutic utility of MIR4690 specifically[1][6][7]. Some sources note an association with osteoblastoma, but the mechanism is undefined. There are no known specific drugs or therapeutic agents targeting MIR4690, nor is it presently used as a clinical biomarker. Critical Limitations: - Biological and clinical data on MIR4690 are extremely limited. Most information currently available is about microRNAs in general; no specific functional studies or disease links for MIR4690 are firmly established in the literature. - MIR4690 is not considered a classic therapeutic target (such as a receptor, enzyme, or transporter) but is part of the gene regulatory machinery as a microRNA. Summary Table | Field | Value | |-------------------------|-------| | canonical_name | MicroRNA 4690 | | canonical_abbreviation | MIR4690 | | is_target | false | | is_incorrect | false | | aliases | hsa-mir-4690, MIR4690, hsa-mir-4690 | | molecular_classifications | microRNA, non-coding RNA | | biological_functions | Regulation of gene expression, post-transcriptional gene silencing, modulation of mRNA stability and translation | | disease_roles | Osteoblastoma (association only); broader role possible via microRNA dysregulation in disease | | interacting_drugs | null | | mechanism_of_action | Post-transcriptional regulation of gene expression via RNA silencing | | biomarkers | null (specific evidence lacking) | | safety_concerns | None specific; general microRNA modulation risks noted | | description | See above | If additional information on MIR4690 becomes available, further specifics regarding targets, disease associations, or druggability may be added. At present, data is based on general knowledge of microRNA biology and limited gene annotation[1][3][5].

Other names

hsa-mir-4690MIR4690

MicroRNAs act by base-pairing to target mRNAs, leading to translational repression or mRNA degradation[3][1]